miR-181-5p/KLHL5 Promoted Proliferation and Migration of Gastric Cancer Through Activating METTL3-Mediated m6A Process
- PMID: 37733183
- DOI: 10.1007/s12033-023-00877-x
miR-181-5p/KLHL5 Promoted Proliferation and Migration of Gastric Cancer Through Activating METTL3-Mediated m6A Process
Abstract
KLHL5 was a member of kelch-repeat protein family and was involved in the initiation of progression of a plethora of cancers. However, its specific role in gastric cancer was not explicitly illustrated. In this context, we aimed to investigate the biological role and mechanisms about KLHL5 in gastric cancer. qRT-PCR and western blot were used to investigate the expression of KLHL5 and EMT biomarkers. Wound healing assay, CCK-8, and Transwell assay were used to investigate the biological function of KLHL5. We found that KLHL5 was highly expressed in gastric cancer both in vivo and in vitro; besides, its high expression led to a shorter overall survival. Following statistical analysis showed that KLHL5 was associated with M stage. As for molecular experiments, we found that KLHL5 knockdown significantly reduced the proliferation, migration, and invasion ability of gastric cancer cell line MKN45 and SGC-7901. Furthermore, we found that miR-181-5p targeted KLHL5 to regulate m6A level through METTL3. In addition, KLHL5 knockdown could significantly reduce the lung metastasis rate in mice. In conclusion, we found that miR-181-5p/KLHL5 could promote the proliferation, migration, and invasion of gastric cancer by activating m6A process through regulating METTL3.
Keywords: Gastric cancer; KLHL5; METTL3; m6A; miR-181-5p.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.Bioengineered. 2021 Dec;12(2):10023-10036. doi: 10.1080/21655979.2021.1994721. Bioengineered. 2021. PMID: 34666602 Free PMC article.
-
Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.Aging (Albany NY). 2021 Apr 21;13(8):12224-12238. doi: 10.18632/aging.103822. Epub 2021 Apr 21. Aging (Albany NY). 2021. PMID: 33882457 Free PMC article.
-
N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.Bioengineered. 2021 Dec;12(1):4081-4091. doi: 10.1080/21655979.2021.1953210. Bioengineered. 2021. PMID: 34288797 Free PMC article.
-
BUB1 potentiates gastric cancer proliferation and metastasis by activating TRAF6/NF-κB/FGF18 through m6A modification.Life Sci. 2024 Sep 15;353:122916. doi: 10.1016/j.lfs.2024.122916. Epub 2024 Jul 16. Life Sci. 2024. PMID: 39025206
-
Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications.Eur J Med Res. 2025 Feb 12;30(1):98. doi: 10.1186/s40001-025-02353-5. Eur J Med Res. 2025. PMID: 39940056 Free PMC article. Review.
Cited by
-
METTL3-Regulated lncRNA SNHG7 Drives MNNG-Induced Epithelial-Mesenchymal Transition in Gastric Precancerous Lesions.Toxics. 2024 Aug 6;12(8):573. doi: 10.3390/toxics12080573. Toxics. 2024. PMID: 39195675 Free PMC article.
-
METTL3 as a potential therapeutic target in gastric cancer.Front Oncol. 2024 Nov 29;14:1483435. doi: 10.3389/fonc.2024.1483435. eCollection 2024. Front Oncol. 2024. PMID: 39678510 Free PMC article. Review.
References
-
- Chen, W., Zheng, R., Baade, P. D., et al. (2016). Cancer statistics in China, 2015. CA: A Cancer Journal for Clinicians., 66(2), 115–132. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials